News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. Clearmind Medicine Inc. (NASDAQ: CMND) today announced that as…
Tag: Results
Risk of hip fracture in meat-eaters, pescatarians, and vegetarians: results from the UK Women’s Cohort Study | BMC Medicine
Dhanwal DK, Dennison EM, Harvey NC, Cooper C. Epidemiology of hip fracture: worldwide geographic variation. Indian J Orthop. 2011;45(1):15–22. PubMed PubMed Central Article Google Scholar Veronese N, Maggi S. Epidemiology…
Lilly’s SURMOUNT-1 results published in The New England Journal of Medicine show tirzepatide achieved between 16.0% and 22.5% weight loss in adults with obesity or overweight
Detailed results from Lilly’s first phase 3 trial in obesity or overweight presented at the American Diabetes Association’s® 82nd Scientific Sessions® and simultaneously published in NEJM INDIANAPOLIS, June 4, 2022 /PRNewswire/ —…
Galmed Pharmaceuticals : Results of Galmed’s Phase 2b ARREST Trial of Aramchol Published in Nature Medicine – Form 6-K
Results from Galmed’s Phase 2b ARREST study with aramchol published in Nature Medicine – The data complements the growing body of clinical and scientific evidence demonstrating the therapeutic potential of…
Cat Financial Announces Second-Quarter 2021 Results
NASHVILLE, Tenn., July 30, 2021 / PRNewswire / – Cat Financial reported revenue of $ 646 million, An increase from $ 5 million, or 1% compared to the second quarter…
The surprising results of my rescue dog’s DNA test
Meet my dog Dobby. Dobby was rescued from a Connecticut animal shelter in the United States by my partner in 2018, and his breed has always been a source of…
AusCann experiences medicinal hashish canine trial outcomes promising | The Examiner
News, Local News, Medical Cannabis, Dogs, Pain Relief, AusCann, CannPaul, Tasmania, USA, Study There is hope for painful boobs, limping Labradoodles and fighting Shih Tzus. A Tasmania-affiliated company has reported…
New England Journal of Drugs Publishes 24-Week Outcomes from Section Three Research Evaluating RINVOQ™ (upadacitinib) in Psoriatic Arthritis
NORTH CHICAGO, Ill., April 1, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the New England Journal of Medicine has published 24-week results from the Phase 3 SELECT-PsA 1…
New Veterinary Advertising Efficiency Examine Delivers Surprising Outcomes
GeniusVets suppresses competition in new marketing results study GeniusVets is redefining dominance by outperforming the rest of the industry combined The best way to understand performance is compared to others…